Fredrik Lehmann

Fredrik Lehmann appears in our data through filings on Sprint Bioscience AB shares, published by Finansinspektionen. The record holds 2 filings, for trades running from 14 November 2019 to 21 November 2023.

Purchases make up the whole of the open-market record (2 purchases, €5,885). Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2023 alone, the filings show 1 purchase and no sales.

The record was last updated on 21 November 2023 with an open-market purchase (€3,673) in Sprint Bioscience AB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.